True North Therapeutics
Focused on developing treatments for rare diseases mediated by the complement system. Acquired by Bioverativ in 2017.
Focused on developing treatments for rare diseases mediated by the complement system. Acquired by Bioverativ in 2017.
Offerers soil microbiome testing services for agriculture. Acquired by Miraterra in 2025.
Created innovative dialysis technologies to improve the efficiency and convenience of treatment for patients with kidney disease. Acquired by Fresenius Medical Care in 2007.
Develops microbiome-targeted medical probiotics for metabolic health.
Develops high-data-rate brain-machine interfaces for medical applications.